All In Biotech

Free tool

FAERS Monitor: Novolin 70/30

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 019991 or its brand name (Novolin 70/30, Insulin Recombinant Human, Insulin Susp Isophane Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

5,946

Serious

3,872

65% of reports

Hospitalization

2,065

Death reported

612

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased902
  • nausea354
  • blood glucose decreased349
  • drug ineffective291
  • dyspnoea287
  • dizziness255
  • fatigue231
  • diarrhoea224
  • death222
  • asthenia208
  • renal failure202
  • weight decreased202
  • vomiting197
  • headache196
  • pain191

Reports by year received

View as table
YearReports
2004113
2005155
2006247
2007183
2008136
2009212
2010247
2011234
2012253
2013217
2014282
2015684
2016430
2017445
2018513
2019449
2020242
2021223
2022163
202398
2024197
2025155
202668

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,213 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal34925.923.48,284
blood glucose increasedSignal90217.016.013,634
renal failureSignal2025.44.7721
weight decreasedSignal2022.62.2193
asthenia2082.01.798
dizziness2551.81.694
dyspnoea2871.81.6103
nausea3541.61.478
vomiting1971.51.331
diarrhoea2241.21.110
headache1961.11.02
pain1911.11.02
fatigue2311.00.91
death2220.90.82
drug ineffective2910.80.719

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.